跳至主要内容
临床试验/NCT04976764
NCT04976764Unknown不适用

Affiliated Hospital of Qingdao University

The Affiliated Hospital of Qingdao University0 个研究点目标入组 850 人开始时间: 2021年8月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
850
主要终点
perioperative cardiovascular events

研究概览

简要总结

Liver transplantation is an effective treatment for end-stage liver disease. Cardiovascular complications are the common causes of death in liver transplant recipients. The presence of cirrhosis cardiomyopathy has a potential impact on the prognosis of liver transplant recipients. Therefore, it is important to identify the high risk factors with cirrhotic cardiomyopathy before transplantation, so as to intervene earlier and improve the prognosis of patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnostic criteria for decompensated liver cirrhosis: according to the guidelines for diagnosis and treatment of liver cirrhosis in 2019;
  • Diagnostic criteria for cirrhotic cardiomyopathy: in accordance with the revised criteria of CCM of international multidisciplinary Alliance for cirrhotic cardiomyopathy in 2019, the preoperative echocardiographic images of all patients were reviewed, and the systolic and diastolic dysfunction of all patients were evaluated.

排除标准

  • the compensatory liver cirrhosis, primary liver cancer without liver cirrhosis
  • Multiple organ transplantation or multiple organ transplantation
  • The preoperative echocardiographic data were not fully recorded, so that the exact diagnosis could not be made
  • There was no follow-up data or baseline data

结局指标

主要结局

perioperative cardiovascular events

时间窗: 2012.1.1-2022.8

there are differences between 2 groups.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验